Kate Harvey

Senior Research Assistant: Swarbrick Lab

Selected Publications

See all publications

2022
Breast cancer research : BCR10.1186/s13058-022-01540-0
Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.
Niantao Deng, Andre Minoche, Kate Harvey, Meng Li, Juliane Winkler, Andrei Goga, Alex Swarbrick
2021
Clinical epigenetics10.1186/s13148-021-01210-6
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Braydon Meyer, Samuel Clifton, Warwick Locke, Phuc-Loi Luu, Qian Du, Dilys Lam, Nicola J Armstrong, Beena Kumar, Niantao Deng, Kate Harvey, Alex Swarbrick, Vinod Ganju, Susan J Clark, Ruth Pidsley, Clare Stirzaker
2021
Nature10.1038/s41586-021-03835-2
Colorimetric histology using plasmonically active microscope slides.
Eugeniu Balaur, Sandra O' Toole, Alex J Spurling, G Bruce Mann, Belinda Yeo, Kate Harvey, Catherine Sadatnajafi, Eric Hanssen, Jacqueline Orian, Keith A Nugent, Belinda S Parker, Brian Abbey
2021
Nature genetics10.1038/s41588-021-00911-1
A single-cell and spatially resolved atlas of human breast cancers.
Sunny Z Wu, Ghamdan Al-Eryani, Daniel Lee Roden, Simon Junankar, Kate Harvey, Alma Andersson, Aatish Thennavan, Chenfei Wang, James R Torpy, Nenad Bartonicek, Taopeng Wang, Ludvig Larsson, Dominik Kaczorowski, Neil I Weisenfeld, Cedric R Uytingco, Jennifer G Chew, Zachary W Bent, Chia-Ling Chan, Vikkitharan Gnanasambandapillai, Charles-Antoine Dutertre, Laurence Gluch, Mun N Hui, Jane Beith, Andrew Parker, Elizabeth Robbins, Davendra Segara, Caroline Cooper, Cindy Mak, Belinda Chan, Sanjay Warrier, Florent Ginhoux, Ewan Millar, Joseph E Powell, Stephen R Williams, X Shirley Liu, Sandra O'Toole, Elgene Lim, Joakim Lundeberg, Charles M Perou, Alexander Swarbrick
2021
The American journal of surgical pathology10.1097/PAS.0000000000001701
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3.
Jia-Min B Pang, Belinda Castles, David J Byrne, Peter Button, Shona Hendry, Sunil R Lakhani, Vanathi Sivasubramaniam, Wendy A Cooper, Jane Armes, Ewan K A Millar, Wendy Raymond, Samuel Roberts-Thomson, Beena Kumar, Marian Burr, Christina Selinger, Kate Harvey, Charles Chan, Jane Beith, David Clouston, Sandra A O'Toole, Stephen B Fox,

See all Garvan publications

Explore our research

Our impact

Our people

News and resources

About us

Support Us

Kate Harvey

Selected Publications

Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.

Colorimetric histology using plasmonically active microscope slides.

A single-cell and spatially resolved atlas of human breast cancers.

SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3.

Garvan researchers selected as Eureka Prize finalists